UBIO

ProShares UltraPro Nasdaq BiotechnologyProShares
AUM$15.1M
Expense Ratio0.95%
NAV$17.77
Holdings1
InceptionJun 22, 2015

Price Chart

Key Statistics

Previous Close

N/A

Day Range

N/A

52-Week Range

N/A

Avg Volume

N/A

Dividend Yield

N/A

Expense Ratio

0.95%

AUM

$15.1M

Shares Outstanding

N/A

Sector Breakdown

SectorWeight %
Healthcare99.96%
Basic Materials0.04%

Country Allocation

CountryWeight %
Other100.00%

Fund Information

Issuer
ProShares
Category
Healthcare
Subcategory
Biotech
Inception Date
Jun 22, 2015
Description
The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index (the index). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Similar ETFs

SymbolNameAUMExpense RatioHoldings
IWMiShares Russell 2000 ETF$70.17B0.19%1,934
XLVState Street Health Care Select Sector SPDR ETF$40.61B0.08%60
VHTVanguard Health Care ETF$19.80B0.09%411
COWZPacer US Cash Cows 100 ETF$18.40B0.49%103
VTWOVanguard Russell 2000 ETF$14.50B0.06%1,969

The ProShares UltraPro Nasdaq Biotechnology (UBIO) is an exchange-traded fund issued by ProShares that launched on Jun 22, 2015. It currently manages $15.1M in assets under management. The fund charges an expense ratio of 0.95%. The fund holds 1 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 100.0% of the fund

RankSymbolNameWeight %SharesMarket Value
1Net Other Assets (Liabilities)100.00%15,100,402$15.1M

Detailed Returns

PeriodReturnETFCat. Avgvs Avg
1D
N/A

Moving Averages

20-Day MA

N/A

50-Day MA

N/A

200-Day MA

N/A

Price with Moving Averages

Support & Resistance

52-Week High

N/A

Current Price

N/A

52-Week Low

N/A

Current Yield

N/A

Annual Dividend

N/A

Frequency

N/A

Last Ex-Date

N/A

Dividends

No dividend data available for this ETF.

Category Comparison

MetricUBIOHealthcare(223 ETFs)Biotech(39 ETFs)
Fund Info
Expense Ratio0.95%0.60%0.84%
AUM$15.1M$1.25B$1.62B
Dividend Yield2.75%14.38%
Avg VolumeN/A769.9K1.3M
Holdings118267
Performance
1-Month Return-3.02%-2.05%
6-Month Return+5.85%+15.05%
YTD Return+0.17%+1.05%
1-Year Return+16.65%+24.43%

Compare with Another ETF

Search for an ETF to compare with UBIO: